Vertex Pharmaceuticals holds the cleaner structural position, with the lead spread across valuation and stability. Arm does not offset that deficit through any equally strong structural edge elsewhere. In the market, Arm carries the stronger setup — intact trend against Vertex Pharmaceuticals's broken trend. That leaves a split case: the structural lead stays with Vertex Pharmaceuticals, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
The clearest separation starts in valuation, but stability adds another real layer to the result. Vertex Pharmaceuticals Incorporated leads by 33 points on the overall comparison score.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
The match is driven mainly by investment intensity and revenue growth trajectory.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Vertex Pharmaceuticals Incorporated looks stronger both structurally and on relative valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The multiple-based pricing edge comes from a forward P/E that is 53 turns lower.
On the market side, Arm carries the stronger trend while Vertex Pharmaceuticals's trend has broken — the market setup does not confirm the structural advantage.
The lead is built on both valuation and stability, making it broader than a single-dimension result.
Break down the ARM vs VRTX comparison across all dimensions with the full interactive tool.
Explore how ARM and VRTX each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.